Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s disease
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
Rolling Out1d
The breakthrough medication reshaping diabetes care
Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.
ConsumerAffairs17h
Here are the health pros and cons of GLP-1RA weight loss drugs
New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...
Here's why researchers think most people stop taking weight loss drugs within a year
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Whose cardiovascular health do SGLT2, GLP-1 diabetes drugs benefit most?
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.
Rolling Out1d
The silent crisis in diabetes care you can’t ignore
Millions with type 2 diabetes face hidden nutrient deficiencies, raising concerns about health risks and the urgent need for dietary intervention.
Medical News Today10d
Calorie restriction plus common diabetes drug leads to higher remission rates
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
Patients using diabetes apps can miss critical alerts. Here’s how to make sure you’re getting them
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
GlobalData on MSN1d
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...